Division of Cardiology, Osaka General Medical Center, 3-1-56, Mandai-Higashi, Sumiyoshi-ku, Osaka 558-8558, Japan.
Division of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):58-66. doi: 10.1093/ehjci/jeaa025.
Cardiac 123I-metaiodobenzylguanidine (123I-MIBG) imaging provides prognostic information in patients with chronic heart failure (HF). However, there is little information available on the prognostic role of cardiac 123I-MIBG imaging in patients admitted for acute decompensated heart failure (ADHF), especially relating to reduced ejection fraction [HFrEF; left ventricular ejection fraction (LVEF) < 40%], mid-range ejection fraction (HFmrEF; 40% ≤ LVEF < 50%) and preserved ejection fraction (HFpEF; LVEF ≥ 50%).
We studied 349 patients admitted for ADHF and discharged with survival. Cardiac 123I-MIBG imaging, echocardiography, and venous blood sampling were performed just before discharge. The cardiac 123I-MIBG heart-to-mediastinum ratio (late H/M) was measured on the chest anterior view images obtained at 200 min after the isotope injection. The endpoint was cardiac events defined as unplanned HF hospitalization and cardiac death. During a follow-up period of 2.1 ± 1.4 years, 128 patients had cardiac events (45/127 in HFrEF, 28/78 in HFmrEF, and 55/144 in HFpEF). On multivariable Cox analysis, late H/M was significantly associated with cardiac events in overall cohort (P = 0.0038), and in subgroup analysis of each LVEF subgroup (P = 0.0235 in HFrEF, P = 0.0119 in HFmEF and P = 0.0311 in HFpEF). Kaplan-Meier analysis showed that patients with low late H/M (defined by median) had significantly greater risk of cardiac events in overall cohort (49% vs. 25% P < 0.0001) and in each LVEF subgroup (HFrEF: 48% vs. 23% P = 0.0061, HFmrEF: 51% vs. 21% P = 0.0068 and HFpEF: 50% vs. 26% P = 0.0026).
Cardiac sympathetic nerve dysfunction was associated with poor outcome in ADHF patients irrespective of HFrEF, HFmrEF, or HFpEF.
心脏 123I-间位碘代苄胍(123I-MIBG)成像可提供慢性心力衰竭(HF)患者的预后信息。然而,关于心脏 123I-MIBG 成像在因急性失代偿性心力衰竭(ADHF)入院的患者中的预后作用,特别是在射血分数降低(HFrEF;左心室射血分数 [LVEF] <40%)、中间范围射血分数(HFmrEF;40%≤LVEF<50%)和保留射血分数(HFpEF;LVEF≥50%)的患者中,相关信息较少。
我们研究了 349 名因 ADHF 入院并存活出院的患者。在出院前进行心脏 123I-MIBG 成像、超声心动图和静脉血采样。在注射同位素后 200 分钟时,在胸部前位图像上测量心脏 123I-MIBG 心/纵隔比(晚期 H/M)。终点是未计划的 HF 住院和心脏死亡定义的心脏事件。在 2.1±1.4 年的随访期间,128 名患者发生了心脏事件(HFrEF 中 45/127,HFmrEF 中 28/78,HFpEF 中 55/144)。多变量 Cox 分析显示,晚期 H/M 与整个队列的心脏事件显著相关(P=0.0038),并且在每个 LVEF 亚组的亚组分析中也是如此(HFrEF 中 P=0.0235,HFmrEF 中 P=0.0119,HFpEF 中 P=0.0311)。Kaplan-Meier 分析显示,整个队列中晚期 H/M 较低(定义为中位数)的患者发生心脏事件的风险显著增加(49%比 25%,P<0.0001),并且在每个 LVEF 亚组中也是如此(HFrEF:48%比 23%,P=0.0061,HFmrEF:51%比 21%,P=0.0068,HFpEF:50%比 26%,P=0.0026)。
心脏交感神经功能障碍与 ADHF 患者的不良预后相关,无论是否存在 HFrEF、HFmrEF 或 HFpEF。